Description: Co-Aprovel 300 by 25 mg Tablets are used to treat high blood pressure (hypertension). This medication combines two active ingredients that work together to relax blood vessels, lower blood pressure, and reduce the risk of cardiovascular events such as strokes and heart attacks.
Ingredients:
-
Active Ingredients:
- 300 mg of Irbesartan (an angiotensin II receptor antagonist)
- 25 mg of Hydrochlorothiazide (a thiazide diuretic)
-
Other Ingredients:
- [List any excipients or additional components, such as lactose, magnesium stearate, etc.]
Usage Instructions:
-
Dosage: One tablet daily, or as prescribed by your healthcare provider.
-
Frequency: Once daily.
-
Special Considerations: Take the tablet with or without food. Swallow the tablet whole with a glass of water. Do not crush or chew the tablet. Consistency in taking the medication at the same time each day is recommended.
Benefits:
- Effectively lowers high blood pressure.
- Reduces the risk of stroke, heart attack, and other cardiovascular complications.
- Combines two medications to provide a more comprehensive treatment of hypertension.
Precautions:
-
Contraindications: Do not use if you are allergic to irbesartan, hydrochlorothiazide, or any other components of the tablet. Not recommended for patients with severe renal impairment, anuria, or hypersensitivity to other sulfonamide-derived drugs.
-
Side Effects: Possible side effects include dizziness, light-headedness, headache, and fatigue. Rare but serious side effects may include electrolyte imbalances, kidney problems, and severe allergic reactions.
-
Warnings: Regular monitoring of blood pressure, kidney function, and electrolyte levels is essential. Inform your healthcare provider of any other medications or supplements you are taking. Use with caution in patients with a history of liver disease, gout, or diabetes.
Storage Instructions:
- Store at room temperature (15°C to 25°C or 59°F to 77°F).
- Keep in a dry place away from light and moisture.
- Keep out of reach of children.
Manufacturer: Sanofi Aventis
